Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R01CA188898-01A1 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.
Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HE + HE | Active Comparator | Participants receive up to two interventions. Participants receive HE initially and then a second time if not screened after 6 months. |
|
| HE + I2 | Active Comparator | Participants receive up to two interventions. Participants receive HE initially and then I2 if not screened after 6 months. |
|
| I2 + I2 | Experimental | Participants receive up to two interventions. Participants receive I2 initially and then a second time if not screened after 6 months. |
|
| I2 + HE | Active Comparator | Participants receive up to two interventions. Participants receive I2 initially and then HE if not screened after 6 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| I2 | Other | A touch screen computer delivered "implementation intentions" (I2) intervention on CRC screening. "Implementation intentions" are the exact steps (the when, what, where, how) one will take to complete a test (the date and time, at home or at the doctor's office, with what supplies, etc.). |
| Measure | Description | Time Frame |
|---|---|---|
| CRC screening completion rate | Rate of participants who receive CRC screening during study participation | 12-14 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Cost analysis of each intervention pathway | Measure will be calculated by estimating all cost factors in the CRC screening process, include personnel and materials/supplies costs, materials development costs, and time of all study staff involved. Measure represented as a per participant cost to complete screening. | 14 Months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Allen Greiner, MD, MPH | University of Kansas Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | United States |
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D003110 | Colonic Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Health Education | Other | Standard of care approach that will provide basic information on CRC screening. |
|
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |